135 results
8-K
TVTX
Travere Therapeutics Inc
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
on February 17, 2021, subject to the satisfaction of customary closing conditions. In addition, we granted the Underwriters a 30-day option to purchase … and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the offering, and those factors disclosed
8-K
TVTX
Travere Therapeutics Inc
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
, subject to the satisfaction of customary closing conditions. In addition, we granted the Underwriters a 30-day option to purchase up to 975,000 … from the forward-looking statements include, but are not limited to, risks and uncertainties associated with market conditions and the satisfaction
S-3ASR
EX-4.12
TVTX
Travere Therapeutics Inc
3 Sep 21
Automatic shelf registration
4:20pm
Notice of Redemption
Section 3.03
Payment Upon Redemption
Section 3.04
Sinking Fund
Section 3.05
Satisfaction of Sinking Fund Payments with Securities … Entity Substituted
ARTICLE 11 SATISFACTION AND DISCHARGE
Section 11.01
Satisfaction and Discharge of Indenture
Section 11.02
Discharge of Obligations
8-K
EX-99.2
TVTX
Travere Therapeutics Inc
11 Mar 22
Travere Announces Proposed Convertible Senior Notes Offering
4:06pm
the satisfaction of certain conditions. Thereafter, the Notes will be convertible at the option of the holders at any time until the close of business … associated with market conditions, the satisfaction of closing conditions related to the
offering, and risks related to the application of the net
S-3
EX-4.11
TVTX
Travere Therapeutics Inc
9 Sep 14
Shelf registration
12:00am
Issuances
ARTICLE FOUR SATISFACTION AND DISCHARGE
Section 4.01. Satisfaction and Discharge of Indenture
Section 4.02. Application of Trust Money … . Satisfaction of Sinking Fund Payments with Securities
Section 12.03. Redemption of Securities for Sinking Fund
ARTICLE THIRTEEN DEFEASANCE
S-3
EX-4.10
5l1w9ihju
9 Sep 14
Shelf registration
12:00am
S-8
EX-5.1
p0ru9js55
18 Aug 22
Registration of securities for employees
4:06pm
S-8
EX-5.1
yvd6tiigw9t
29 Jul 21
Registration of securities for employees
4:16pm
S-8
EX-5.1
lf5de1ygcv3
11 May 18
Registration of securities for employees
12:00am
S-8
EX-5.1
qbi4g8c 2i
26 Jul 19
Registration of securities for employees
4:21pm
S-8
EX-5.1
agnxms8n cv1lvm8ygzx
30 Jul 20
Registration of securities for employees
9:50pm
8-K
EX-5.1
0l1l73a
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-5.1
0aglcrggdbad4b1
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
8-K
EX-99.1
ih6mh 732h7l4
12 Aug 14
Retrophin Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
ognas grzn
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
8-K
EX-99.1
8rd55cjkg0t bs
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-99.2
y9vcbb gpcv2
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
8-K
3y1b3bhq5fk
4 Apr 14
Changes in Registrant's Certifying Accountant
12:00am